Detroit-based Caraco Pharmaceutical Laboratories Ltd. (NYSE Amex: CPD) said Tuesday that it had entered into a merger agreement Monday with Sun Pharmaceutical Industires Ltd., an Indian pharma firm that already owns 75.8 percent of Caraco’s stock.
Detroit generic pharmaceutical maker loses a distribution agreement with India’s Sun Pharma, its majority owner, a year from now, and will face a delay getting back into pharma production at its own plant.
Detroit-based Caraco Pharmaceutical Laboratories Ltd. reported a net loss vs. net income in its second fiscal quarter ended Sept. 30, but the year-ago profit was prompted by $20 million in one-time income, part of an […]
Detroit-based Caraco Pharmaceutical Laboratories Ltd. (NYSE AMEX: CPD) reported net income of $1.2 million in the first quarter of its fiscal year, compared to a loss of $9.4 million a year earlier. Last fiscal year, […]